+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Optical Imaging Market by Product Type, Therapeutic Area, and End User: Global Opportunity Analysis and Industry Forecast, 2021-2030

  • PDF Icon

    Report

  • 238 Pages
  • November 2021
  • Region: Global
  • Allied Market Research
  • ID: 5533799
Description Jump to:
The global optical imaging market was valued at $1,386.8 million in 2020, and is projected to reach $3,865.7 million by 2030, registering a CAGR of 10.8% from 2021 to 2030.



Optical imaging involves the use of light waves to create 2D and 3D images of organs, tissues, and cells. An optical image is formed by a lens or mirror system from reflected, refracted, or diffracted light waves. Thus, optical imaging requires imaging systems, illuminating systems, and lenses. Moreover, the device requires a software program, which assists in its operations.

In addition, some of the major medical fields where optical imaging is used include ophthalmology, oncology, and cardiology. Diffuse optical imaging may be employed in particular to obtain images of soft tissues, such as breast and brain tissue. Furthermore, diffuse optical imaging is being studied as an imaging test to help diagnose early-stage breast cancer and other conditions.

The major factor that drives the growth of the global optical imaging market includes rise in prevalence of eye disorders such as glaucoma and cataract. Furthermore, surge in government initiatives to control visual impairment and increase in geriatric population act as the key driving forces of the market. Elderly individuals are highly prone to conditions such as neurology disorders, ophthalmic conditions, and cardiovascular conditions. Thus, increase in prevalence of such conditions propels the need for optical imaging devices, which notably contributes toward the growth of the global market.

However, lack of access to optical imaging in underdeveloped countries hinders the growth of the market. On the contrary, developing nations exhibit high growth potential, owing to surge in investments in healthcare-related infrastructure and rise in awareness related to optical imaging.

Another major factor that has greatly disrupted the optical imaging market includes the COVID-19 outbreak. The optical imaging industry was hit negatively as the demand for optical imaging fell in the period of strict lockdown. Furthermore, the major players operating in market suffered from supply chain disruptions due to the COVID-19 outbreak. For instance, the shortage in staff numbers in supply chain due to the pandemic negatively impacted the market.

The global optical imaging market is segmented into product type, therapeutic area, end user, and region. On the basis of product type, the market is categorized into imaging systems, software, camera, lenses, and illumination systems. The imaging systems segment is further bifurcated into optical imaging systems and spectral imaging systems. Depending on therapeutic area, the market is segregated into ophthalmology, oncology, cardiology, neurology, others. By end user, it is fragmented into hospitals & clinics, research laboratories, and pharmaceuticals & biotechnology companies. Region wise, it is analyzed across North America (U.S., Canada, and Mexico) Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and rest of Asia Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA.

The major players operating in the optical imaging market are Abbott Laboratories, Canon Inc., Carl Zeiss Foundation, Cylite Pty Ltd., Danaher Corporation, Heildelberg Engineering GmbH, Koninklijke Philips N.V., Michelson Diagnostics Ltd., Optovue, Ltd., and Topcon Corporation.

KEY BENEFITS FOR STAKEHOLDERS

  • This report entails a detailed quantitative analysis of the current market trends from 2021 to 2030 to identify the prevailing opportunities along with strategic assessment of the global optical imaging market.
  • Market size and estimations are based on a comprehensive analysis of the end users, developments, and services in the industry.
  • An in-depth analysis based on regions assists to understand the regional market and facilitate the strategic business planning.
  • The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market.

KEY MARKET SEGMENTS


By Product Type

  • Imaging systems
  • Optical imaging systems
  • Spectral imaging systems
  • Software
  • Camera
  • Lenses
  • Illumination systems

By Therapeutic Area

  • Ophthalmology
  • Oncology
  • Cardiology
  • Neurology
  • Others

By End User

  • Hospitals & clinics
  • Research laboratories
  • Pharmaceuticals & biotechnology companies

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

  • Abbott Laboratories
  • Canon Inc.
  • Carl Zeiss Foundation
  • Cylite Pty Ltd.
  • Danaher Corporation
  • Heildelberg Engineering GmbH
  • Koninklijke Philips N.V.
  • Michelson Diagnostics Ltd.
  • Optovue, Ltd.
  • Topcon Corporation

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.3.1. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. Key findings of the study
2.2. CXO perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2020
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Increase in prevalence of eye disorders
3.5.1.2. Surge in government initiatives to control visual impairment
3.5.1.3. Increase in geriatric population
3.5.2. Restraint
3.5.2.1. Lack of access to optical imaging in underdeveloped countries
3.5.3. Opportunity
3.5.3.1. High market growth potential in emerging markets
3.5.4. Impact analysis
3.6. COVID-19 impact analysis on optical imaging market
CHAPTER 4: OPTICAL IMAGING MARKET, BY PRODUCT TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Imaging systems
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.2.4. Market size and forecast, by type
4.2.4.1. Optical imaging systems
4.2.4.1.1. Market size and forecast
4.2.4.2. Spectral imaging systems
4.2.4.2.1. Market size and forecast
4.3. Software
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Lenses
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Camera
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast
4.5.3. Market analysis, by country
4.6. Illumination systems
4.6.1. Key market trends, growth factors, and opportunities
4.6.2. Market size and forecast, by region
4.6.3. Market analysis, by country
CHAPTER 5: OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA
5.1. Overview
5.1.1. Market size and forecast
5.2. Ophthalmology
5.2.1. Market size and forecast, by region
5.2.2. Market analysis, by country
5.3. Oncology
5.3.1. Market size and forecast, by region
5.3.2. Market analysis, by country
5.4. Cardiology
5.4.1. Market size and forecast, by region
5.4.2. Market analysis, by country
5.5. Neurology
5.5.1. Market size and forecast, by region
5.5.2. Market analysis, by country
5.6. Others
5.6.1. Market size and forecast, by region
5.6.2. Market analysis, by country
CHAPTER 6: OPTICAL IMAGING MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals & clinics
6.2.1. Market size and forecast, by region
6.2.2. Market analysis, by country
6.3. Research laboratories
6.3.1. Market size and forecast, by region
6.3.2. Market analysis, by country
6.4. Pharmaceuticals & biotechnology companies
6.4.1. Market size and forecast, by region
6.4.2. Market analysis, by country
CHAPTER 7: OPTICAL IMAGING MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by country
7.2.2.1. U.S.
7.2.2.1.1. U.S. optical imaging market, by product type
7.2.2.1.2. U.S. optical imaging market, by therapeutic area
7.2.2.1.3. U.S. optical imaging market, by end user
7.2.2.2. Canada
7.2.2.2.1. Canada optical imaging market, by product type
7.2.2.2.2. Canada optical imaging market, by therapeutic area
7.2.2.2.3. Canada optical imaging market, by end user
7.2.2.3. Mexico
7.2.2.3.1. Mexico optical imaging market, by product type
7.2.2.3.2. Mexico optical imaging market, by therapeutic area
7.2.2.3.3. Mexico optical imaging market, by end user
7.2.3. North America market size and forecast, by product type
7.2.4. North America market size and forecast, by therapeutic area
7.2.5. North America market size and forecast, by end user
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by country
7.3.2.1. Germany
7.3.2.1.1. Germany optical imaging market, by product type
7.3.2.1.2. Germany optical imaging market, by therapeutic area
7.3.2.1.3. Germany optical imaging market, by end user
7.3.2.2. France
7.3.2.2.1. France optical imaging market, by product type
7.3.2.2.2. France optical imaging market, by therapeutic area
7.3.2.2.3. France optical imaging market, by end user
7.3.2.3. UK
7.3.2.3.1. UK optical imaging market, by product type
7.3.2.3.2. UK optical imaging market, by therapeutic area
7.3.2.3.3. UK optical imaging market, by end user
7.3.2.4. Italy
7.3.2.4.1. Italy optical imaging market, by product type
7.3.2.4.2. Italy optical imaging market, by therapeutic area
7.3.2.4.3. Italy optical imaging market, by end user
7.3.2.5. Spain
7.3.2.5.1. Spain optical imaging market, by product type
7.3.2.5.2. Spain optical imaging market, by therapeutic area
7.3.2.5.3. Spain optical imaging market, by end user
7.3.2.6. Rest of Europe
7.3.2.6.1. Rest of Europe optical imaging market, by product type
7.3.2.6.2. Rest of Europe optical imaging market, by therapeutic area
7.3.2.6.3. Rest of Europe optical imaging market, by end user
7.3.3. Europe market size and forecast, by product type
7.3.4. Europe market size and forecast, by therapeutic area
7.3.5. Europe market size and forecast, by end user
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by country
7.4.2.1. Japan
7.4.2.1.1. Japan optical imaging market, by product type
7.4.2.1.2. Japan optical imaging market, by therapeutic area
7.4.2.1.3. Japan optical imaging market, by end user
7.4.2.2. China
7.4.2.2.1. China optical imaging market, by product type
7.4.2.2.2. China optical imaging market, by therapeutic area
7.4.2.2.3. China optical imaging market, by end user
7.4.2.3. Australia
7.4.2.3.1. Australia optical imaging market, by product type
7.4.2.3.2. Australia optical imaging market, by therapeutic area
7.4.2.3.3. Australia optical imaging market, by end user
7.4.2.4. India
7.4.2.4.1. India optical imaging market, by product type
7.4.2.4.2. India optical imaging market, by therapeutic area
7.4.2.4.3. India optical imaging market, by end user
7.4.2.5. South Korea
7.4.2.5.1. South Korea optical imaging market, by product type
7.4.2.5.2. South Korea optical imaging market, by therapeutic area
7.4.2.5.3. South Korea optical imaging market, by end user
7.4.2.6. Rest of Asia-Pacific
7.4.2.6.1. Rest of Asia-Pacific optical imaging market, by product type
7.4.2.6.2. Rest of Asia-Pacific optical imaging market, by therapeutic area
7.4.2.6.3. Rest of Asia-Pacific optical imaging market, by end user
7.4.3. Asia-Pacific market size and forecast, by product type
7.4.4. Asia-Pacific market size and forecast, by therapeutic area
7.4.5. Asia-Pacific market size and forecast, by end user
7.5. LAMEA
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by country
7.5.2.1. Brazil
7.5.2.1.1. Brazil optical imaging market, by product type
7.5.2.1.2. Brazil optical imaging market, by therapeutic area
7.5.2.1.3. Brazil optical imaging market, by end user
7.5.2.2. Saudi Arabia
7.5.2.2.1. Saudi Arabia optical imaging market, by product type
7.5.2.2.2. Saudi Arabia optical imaging market, by therapeutic area
7.5.2.2.3. Saudi Arabia optical imaging market, by end user
7.5.2.3. South Africa
7.5.2.3.1. South Africa optical imaging market, by product type
7.5.2.3.2. South Africa optical imaging market, by therapeutic area
7.5.2.3.3. South Africa optical imaging market, by end user
7.5.2.4. Rest of LAMEA
7.5.2.4.1. Rest of LAMEA optical imaging market, by product type
7.5.2.4.2. Rest of LAMEA optical imaging market, by therapeutic area
7.5.2.4.3. Rest of LAMEA optical imaging market, by end user
7.5.3. LAMEA market size and forecast, by product type
7.5.4. LAMEA market size and forecast, by therapeutic area
7.5.5. LAMEA market size and forecast, by end user
CHAPTER 8: COMPANY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.1.6. Key strategic moves and developments
8.2. CANON INC.
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. CARL ZEISS FOUNDATION (CARL ZEISS MEDITEC AG)
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.4. CYLITE PTY LTD.
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Key strategic moves and developments
8.5. DANAHER CORPORATION (LEICA MICROSYSTEMS GMBH)
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.6. HEIDELBERG ENGINEERING GMBH (HEIDELBERG ENGINEERING INC.)
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Key strategic moves and developments
8.7. KONINKLIJKE PHILIPS N.V
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Operating business segments
8.7.4. Product portfolio
8.7.5. Business performance
8.8. MICHELSON DIAGNOSTICS LTD.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.9. OPTOVUE, LTD.
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.9.5. Key strategic moves and developments
8.10. TOPCON CORPORATION (TOPCON HEALTHCARE)
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
8.10.6. Key strategic moves and developments
List of Tables
TABLE 01. OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)
TABLE 02. OPTICAL IMAGING MARKET FOR IMAGING SYSTEMS, BY REGION, 2020-2030($MILLION)
TABLE 03. OPTICAL IMAGING MARKET FOR IMAGING SYSTEMS, BY TYPE, 2020–2030 ($MILLION)
TABLE 04. OPTICAL IMAGING MARKET FOR SOFTWARE, BY REGION, 2020-2030($MILLION)
TABLE 05. OPTICAL IMAGING MARKET FOR LENSES, BY REGION, 2020-2030($MILLION)
TABLE 06. OPTICAL IMAGING MARKET FOR CAMERA, BY REGION, 2020–2030 ($MILLION)
TABLE 07. OPTICAL IMAGING MARKET FOR ILLUMINATION SYSTEMS, BY REGION, 2020-2030($MILLION)
TABLE 08. OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020-2030 ($MILLION)
TABLE 09. OPTICAL IMAGING MARKET FOR OPHTHALMOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 10. OPTICAL IMAGING MARKET FOR ONCOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 11. OPTICAL IMAGING MARKET FOR CARDIOLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 12. OPTICAL IMAGING MARKET FOR NEUROLOGY, BY REGION, 2020-2030 ($MILLION)
TABLE 13. OPTICAL IMAGING MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 14. OPTICAL IMAGING MARKET, BY END USER, 2020-2030 ($MILLION)
TABLE 15. OPTICAL IMAGING MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2030($MILLION)
TABLE 16. OPTICAL IMAGING MARKET FOR RESEARCH LABORATORIES, BY REGION, 2020-2030($MILLION)
TABLE 17. OPTICAL IMAGING MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY REGION, 2020-2030 ($MILLION)
TABLE 18. OPTICAL IMAGING MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 19. NORTH AMERICA OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 20. U.S. OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 21. U.S. OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 22. U.S. OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 23. CANADA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 24. CANADA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 25. CANADA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 26. MEXICO OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 27. MEXICO OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 28. MEXICO OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 29. NORTH AMERICA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 30. NORTH AMERICA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 31. NORTH AMERICA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 32. EUROPE OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 33. GERMANY OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 34. GERMANY OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 35. GERMANY OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 36. FRANCE OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 37. FRANCE OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 38. FRANCE OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 39. UK OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 40. UK OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 41. UK OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 42. ITALY OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 43. ITALY OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 44. ITALY OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 45. SPAIN OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 46. SPAIN OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 47. SPAIN OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 48. REST OF EUROPE OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 49. REST OF EUROPE OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 50. REST OF EUROPE OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 51. EUROPE OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 52. EUROPE OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 53. EUROPE OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 54. ASIA-PACIFIC OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 55. JAPAN OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 56. JAPAN OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 57. JAPAN OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 58. CHINA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 59. CHINA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 60. CHINA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 61. AUSTRALIA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 62. AUSTRALIA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 63. AUSTRALIA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 64. INDIA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 65. INDIA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 66. INDIA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 67. SOUTH KOREA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 68. SOUTH KOREA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 69. SOUTH KOREA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 72. REST OF ASIA-PACIFIC OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 73. ASIA-PACIFIC OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 74. ASIA-PACIFIC OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 75. ASIA-PACIFIC OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 76. LAMEA OPTICAL IMAGING MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 77. BRAZIL OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 78. BRAZIL OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 79. BRAZIL OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 80. SAUDI ARABIA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 81. SAUDI ARABIA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 82. SAUDI ARABIA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 83. SOUTH AFRICA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 84. SOUTH AFRICA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 85. SOUTH AFRICA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 86. REST OF LAMEA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 87. REST OF LAMEA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 88. REST OF LAMEA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 89. LAMEA OPTICAL IMAGING MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)
TABLE 90. LAMEA OPTICAL IMAGING MARKET, BY THERAPEUTIC AREA, 2020–2030 ($MILLION)
TABLE 91. LAMEA OPTICAL IMAGING MARKET, BY END USER, 2020–2030 ($MILLION)
TABLE 92. ABBOTT: COMPANY SNAPSHOT
TABLE 93. ABBOTT: OPERATING SEGMENTS
TABLE 94. ABBOTT: PRODUCT PORTFOLIO
TABLE 95. ABBOTT: KEY DEVELOPMENTS
TABLE 96. CANON: COMPANY SNAPSHOT
TABLE 97. CANON: OPERATING SEGMENTS
TABLE 98. CANON: PRODUCT PORTFOLIO
TABLE 99. CANON: KEY DEVELOPMENTS
TABLE 100. CARL ZEISS: COMPANY SNAPSHOT
TABLE 101. CARL ZEISS: PRODUCT SEGMENTS
TABLE 102. CARL ZEISS: PRODUCT PORTFOLIO
TABLE 103. CYLITE: COMPANY SNAPSHOT
TABLE 104. CYLITE: OPERATING BUSINESS SEGMENT
TABLE 105. CYLITE: PRODUCT PORTFOLIO
TABLE 106. CYLITE: KEY DEVELOPMENTS
TABLE 107. DANAHER: COMPANY SNAPSHOT
TABLE 108. DANAHER: PRODUCT SEGMENTS
TABLE 109. DANAHER: PRODUCT PORTFOLIO
TABLE 110. HEILDELBERG: COMPANY SNAPSHOT
TABLE 111. HEILDELBERG: PRODUCT SEGMENTS
TABLE 112. HEILDELBERG: PRODUCT PORTFOLIO
TABLE 113. HEILDELBERG: KEY DEVELOPMENTS
TABLE 114. PHILIPS: COMPANY SNAPSHOT
TABLE 115. PHILIPS: PRODUCT SEGMENTS
TABLE 116. PHILIPS: PRODUCT PORTFOLIO
TABLE 117. MICHELSON: COMPANY SNAPSHOT
TABLE 118. OPTOVUE: OPERATING BUSINESS SEGMENTS
TABLE 119. MICHELSON: PRODUCT PORTFOLIO
TABLE 120. OPTOVUE: COMPANY SNAPSHOT
TABLE 121. OPTOVUE: OPERATING BUSINESS SEGMENTS
TABLE 122. OPTOVUE: PRODUCT PORTFOLIO
TABLE 123. OPTOVUE: KEY DEVELOPMENTS
TABLE 124. TOPCON: COMPANY SNAPSHOT
TABLE 125. TOPCON: OPERATING SEGMENTS
TABLE 126. TOPCON: PRODUCT PORTFOLIO
TABLE 127. TOPCON: KEY DEVELOPMENTS
List of Figures
FIGURE 01. GLOBAL OPTICAL IMAGING MARKET SEGMENTATION
FIGURE 02. TOP INVESTMENT POCKETS
FIGURE 03. TOP WINNING STRATEGIES, BY YEAR, 2019-2021
FIGURE 04. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021
FIGURE 05. TOP WINNING STRATEGIES, BY COMPANY, 2019-2021
FIGURE 06. HIGH BARGAINING POWER OF SUPPLIERS
FIGURE 07. MODERATE BARGAINING POWER OF BUYERS
FIGURE 08. HIGH THREAT OF SUBSTITUTES
FIGURE 09. MODERATE THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE INTENSITY OF RIVALRY
FIGURE 11. TOP PLAYER POSITIONING, 2020
FIGURE 12. IMPACT ANALYSIS
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING SYSTEMS MARKET, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14. OPTICAL IMAGING SYSTEMS MARKET, 2020–2030 ($MILLION)
FIGURE 15. SPECTRAL IMAGING SYSTEMS MARKET, 2020–2030 ($MILLION)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING MARKET FOR SOFTWARE, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING MARKET FOR LENSES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18. COMPARATIVE ANALYSIS OF OPTICAL IMAGING MARKET FOR CAMERA, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19. COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING MARKET FOR ILLUMINATION SYSTEMS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20. COMPARATIVE ANALYSIS OF OPTICAL IMAGING MARKET FOR OPHTHALMOLOGY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21. COMPARATIVE ANALYSIS OF OPTICAL IMAGING MARKET FOR ONCOLOGY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22. COMPARATIVE ANALYSIS OF OPTICAL IMAGING MARKET FOR CARDIOLOGY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 23. COMPARATIVE ANALYSIS OF OPTICAL IMAGING MARKET FOR NEUROLOGY, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 24. COMPARATIVE ANALYSIS OF OPTICAL IMAGING MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 25. COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 26. COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING MARKET FOR RESEARCH LABORATORIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 27. COMPARATIVE SHARE ANALYSIS OF OPTICAL IMAGING MARKET FOR PHARMACEUTICALS & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 28. ABBOTT: NET SALES, 2018–2020 ($MILLION)
FIGURE 29. ABBOTT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30. ABBOTT: REVENUE SHARE BY REGION, 2020(%)
FIGURE 31. CANON: NET SALES, 2018–2020 ($MILLION)
FIGURE 32. CANON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 33. CANON: REVENUE SHARE BY REGION, 2020(%)
FIGURE 34. DANAHER: NET SALES, 2018–2020 ($MILLION)
FIGURE 35. DANAHER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 36. DANAHER: REVENUE SHARE BY REGION, 2020(%)
FIGURE 37. PHILIPS: NET SALES, 2018–2020 ($MILLION)
FIGURE 38. PHILIPS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 39. PHILIPS: REVENUE SHARE BY REGION, 2020(%)
FIGURE 40. TOPCON: NET SALES, 2019–2020 ($MILLION)
FIGURE 41. TOPCON: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42. TOPCON: REVENUE SHARE BY REGION, 2020 (%)

Companies Mentioned

  • Abbott Laboratories
  • Canon Inc.
  • Carl Zeiss Foundation
  • Cylite Pty Ltd.
  • Danaher Corporation
  • Heildelberg Engineering GmbH
  • Koninklijke Philips N.V.
  • Michelson Diagnostics Ltd.
  • Optovue Ltd.
  • Topcon Corporation

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages238
PublishedNovember 2021
Forecast Period2020 - 2030
Estimated Market Value ( USD ) in 2020 $ 1386.8 million
Forecasted Market Value ( USD ) by 2030 $ 3865.7 million
Compound Annual Growth Rate10.8%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Global Optical Imaging Market by Product (Imaging Systems, Software), Technique (Fluorescence Imaging, Near Infrared Spectroscopy, Optical Coherence Tomography), Therapeutic Area, End-User, Application - Forecast 2024-2030 - Product Image

Global Optical Imaging Market by Product (Imaging Systems, Software), Technique (Fluorescence Imaging, Near Infrared Spectroscopy, Optical Coherence Tomography), Therapeutic Area, End-User, Application - Forecast 2024-2030

  • Report
  • 190 Pages
  • Global
From
Global Optical Imaging System Market by Technology (Hyperspectral Imaging, Near-Infrared Spectroscopy, Optical Coherence Tomography), Product (Cameras, Illumination Systems, Imaging Systems), Therapeutic Area, Application, End User - Forecast 2024-2030 - Product Image

Global Optical Imaging System Market by Technology (Hyperspectral Imaging, Near-Infrared Spectroscopy, Optical Coherence Tomography), Product (Cameras, Illumination Systems, Imaging Systems), Therapeutic Area, Application, End User - Forecast 2024-2030

  • Report
  • 197 Pages
  • Global
From
Global Optical Imaging Systems Market Size, Share & Trends Analysis Report by Technology, Product, Application (Pathological, Intraoperative), Therapeutic Area, End Use, Region, and Segment Forecasts, 2023-2030 - Product Image

Global Optical Imaging Systems Market Size, Share & Trends Analysis Report by Technology, Product, Application (Pathological, Intraoperative), Therapeutic Area, End Use, Region, and Segment Forecasts, 2023-2030

  • Report
  • 110 Pages
  • Global
From
Optical Imaging System Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030 - Product Image

Optical Imaging System Market Growth Analysis Report - Latest Trends, Driving Factors and Key Players Research to 2030

  • Report
  • 146 Pages
  • Global
From
Global Optical Imaging Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis - Product Image

Global Optical Imaging Market (2023-2028) Competitive Analysis, Impact of Covid-19, Ansoff Analysis

  • Report
  • 178 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.